Platform
Features
Pricing
0 followers
reMYND drives the development of disease-modifying treatments against protein misfolding disorders.
Industries
Headquarters
Employees
Links
Gerard Griffioen
3 members
1 members
4D Molecular Therapeutics
3 followers
Pivot Bio
2 followers
Quantum-Si
Jnana Therapeutics
1 follower
Sonoma Biotherapeutics
Thermo Fisher Scientific
159 followers
Regeneron
91 followers
Roivant Sciences
56 followers
Natera
13 followers
10X Genomics
QIAGEN
8 followers
Explore companies